A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 10, 2009, Pages 1315-1321

  He, Hong ^a   Chen, Guanfu ^a   Zhou, Liang ^a   Liu, Yanmin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Carcinoembryonic antigen; Carcinoma associated antigen CA 50; Oral tumor; Saliva

Indexed keywords

CA 50 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH TUMOR; PRIORITY JOURNAL; PROGNOSIS; SALIVA ANALYSIS; SALIVARY GLAND TUMOR; VENOUS BLOOD;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SALIVA; SALIVARY GLAND NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 69049117210     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0572-x     Document Type: Article

References (26)

1. M Airoldi P Piantino D Pacchioni, et al. 1986 Gastrointestinal cancer-associated antigen (GICA) in oral carcinoma Oral Surg Oral Med Oral Pathol 61 3 263
2. A Angelov A Klissarova K Dikranian 1996 Radioimmunological and immunohistochemical study of carcinoembryonic antigen in pleomorphic adenoma and mucoepidermoid carcinoma of the salivary glands Gen Diagn Pathol 141 3-4 229 234
3. W Cai H Zheng J Sheng, et al. 1996 Initial study of joint detection of serum CA-50, CA19-9, CEA, and SA for diagnosis of gastric cancer J Fujian Med Coll 30 3 239 242
4. J Chao J Song C Xie, et al. 1998 Diagnostic value of saliva and serum carbohydrate antigen CA-50 detection for parotid tumor Yunnan Med 19 6 402 404
5. K Charalabopoulos A Karakosta G Bablekos, et al. 2007 CEA levels in serum and BAL in patients suffering from lung cancer Med Oncol 24 2 219 225
6. G Chen C Sun J Yan, et al. 1993 Clinical significance of saliva CEA detection for diagnosis of head and neck malignant tumor J Pract Oncol 8 2 94 95
7. N Duraker AN Çelik 2001 The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA J Surg Oncol 7 4 266 271
8. N Duraker S Hot Y Polat, et al. 2007 CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice J Surg Oncol 95 2 142 147
9. B Engarås L Hafström J Kewenter, et al. 1999 Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60-64 years without malignant disease Eur J Surg 165 2 110 116
10. S Guo Y Luo H Wang 1998 Diagnostic significance of five markers for malignant pleural effusion J Chin Pract Med 18 5 279 280
11. H Gustafsson L Franzén K Grankvist, et al. 1988 Glycoprotein tumour markers in head and neck neoplasms-a consecutive study on CA-50, CA 19-9, and CEA J Cancer Res Clin Oncol 114 4 394 398
12. AD Inglot F Gelder A Jerzy 1998 Georgiades tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system Biotherapy 11 1 27 37
13. D Japink M Nap M Leers, et al. 2008 T1118 CEA in activated macrophages: a new prognostic or diagnostic factor for early detection of local recurrence of colorectal neoplasms? Gastroenterology 134 4 A-487
14. DY Kim HR Kim JH Shim, et al. 2000 Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients J Surg Oncol 74 3 185 192
15. H Koike D Ichikawa H Ikoma, et al. 2004 Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients J Surg Oncol 87 4 182 186
16. F Koizumi H Odagiri H Fujimoto, et al. 1992 Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer Rinsho Byori 40 5 523 528
17. D Marrelli E Pinto A De Stefano, et al. 2001 Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer J Surg Oncol 78 4 253 258
18. R Murase Y Abe T Sumida, et al. 2008 Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma China J Oral Maxillofac Surg 6 B05 205 206
19. J Niklinski M Furman 1995 Clinical tumour markers in lung cancer Eur J Cancer Prev 4 2 129 138
20. O Nilsson C Johansson B Glimelius, et al. 1992 Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9 Br J Cancer 65 2 215 221
21. F Safi R Bittner R Roscher, et al. 1986 The value of CEA and/or CA 19-9 serum course in the regional chemotherapy of liver metastases from colorectal carcinoma J Cancer Res Clin Oncol 111 S1 S99
22. SS Sawant SM Zingde MM Vaidya 2008 Cytokeratin fragments in the serum: their utility for the management of oral cancer Oral Oncol 44 8 722 732
23. E Seregni A Coli N Mazzucca, et al. 2004 Circulating tumor marker in breast cancer Eur J Nucl Med Mol Imaging 31 S15 S22
24. Z Wang C Xia G Huang, et al. 1998 Clinical significance of quantitative detection of CEA in salivary, gastric fluid, and blood Abdom Surg 11 1 30
25. H Wang X Feng Y An, et al. 1999 Clinical significance of saliva CEA and IgA detection for patients with oral-stomatology malignant tumor J Pract Stomatol 15 6 447 448
26. E Zolotarevsky RS Kwon GH Elta, et al. 2008 Fluid CEA level is more influential than DNA mutational analysis in guiding clinical management of pancreatic cystic lesions Gastrointest Endosc 67 5 AB214 AB215